Security key
09071M304
BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX)
CUSIP: 09071M304
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Ordinary Shares, par value NIS 0.10 per share
- Total 13F shares
- 20,064
- Total 13F value
- $4,294
- Share change
- +20,064
- SEC-reported price per share
- $0.21
- Number of holders
- 1
- Value change
- +$4,294
- Number of buys
- 1
- Shares outstanding
- 2,402,091,667
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
1
Top holders
1
BLRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
BioLineRx Ltd. SEC filings
BioLineRx Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09071M304
Recent filing periods:
Ownership snapshot
Top reported holders of BLRX - BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Alyeska Investment Group,...
Disclosed value leader
Alyeska Investment Group,...
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
Lead comparable stake: 0.04%
Showing 1-6 of 15 holder rows.
Quick read
Alyeska Investment Group, L.P. leads the comparable SEC ownership view at 0.04%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Alyeska Investment Group, L.P.'s linked filing trail.
Comparable ownership
Top 5
Alyeska Investment Group, L.P.
0.04%
ENVESTNET ASSET MANAGEMENT INC
0.01%
MORGAN STANLEY
0.01%
Values First Advisors, Inc.
0.01%
PVG ASSET MANAGEMENT CORP
0.01%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. |
13F
Company
|
0.04%
|
$464,528
866,495 shares
|
— | 30 Sep 2024 |
| ENVESTNET ASSET MANAGEMENT INC |
13F
Company
|
0.01%
|
$128,228
239,186 shares
|
— | 30 Sep 2024 |
| MORGAN STANLEY |
13F
Company
|
0.01%
|
$105,899
197,537 shares
|
— | 30 Sep 2024 |
| Values First Advisors, Inc. |
13F
Company
|
0.01%
|
$105,888
197,516 shares
|
— | 30 Sep 2024 |
| PVG ASSET MANAGEMENT CORP |
13F
Company
|
0.01%
|
$84,282
157,215 shares
|
— | 30 Sep 2024 |
| Atria Investments, Inc |
13F
Company
|
0.01%
|
$71,823
133,974 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
20,064
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q4 2025 Across Filers
Q4 2025 holders
13
Q4 2024 holders
1
Holder diff
-12
| Investor | Q4 2025 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q4 2025 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend